Table 3.
Group | Group | Medication (LAC 720/yr, RIF 13,200/yr) | HCUP (38.5/6days) | Combined | Total Mean Costs Per Patient | Costs Range Per Patient | P-value |
---|---|---|---|---|---|---|---|
(1) LAC | (1) | 73,440 | 3,927,000 | 4,000,440 | 61,545 | 39,220–122,545 | |
(2) RIF | (2) | 422,400 | 847,000 | 1,269,400 | 39,669 | 14,609–90,450 | 0.025 |
(3) LAC + RIF | (3) | 570,720 | 1,501,500 | 2,072,220 | 50,542 | 26,339–105,666 | 0.055 |
Note: LAC (lactulose), RIF (rifaximin). Data analysis of patients suffering from HE treated with either single agent of in combination therapy. Overall costs include medication and hospital care for comparison amongst the three groups. The data demonstrates combined expenses of medications and hospitalizations over a 12 month period.